doi: 10.1021/jm900846f.
Synthesis of new thienyl ring containing HIV-1 protease inhibitors: promising preliminary pharmacological evaluation against recombinant HIV-1 proteases
Affiliations
- PMID: 20108932
- DOI: 10.1021/jm900846f
Item in Clipboard
Synthesis of new thienyl ring containing HIV-1 protease inhibitors: promising preliminary pharmacological evaluation against recombinant HIV-1 proteases
J Med Chem.
.
Abstract
A series of new thienyl ring containing analogues of nelfinavir and saquinavir with different substitution patterns were synthesized from suitable enantiopure diols. Their inhibitory activity against wild type recombinant HIV-1 protease was evaluated. In general thienyl groups spaced from the core by a methylene group gave products showing IC(50) in the nanomolar range, irrespective of the type and the substitution pattern of the heterocycle. The range of activity of the two most active compounds is substantially maintained or even increased against two commonly selected mutants, under drug pressure, such as V32I and V82A.
Similar articles
-
Prodrugs of HIV protease inhibitors-saquinavir, indinavir and nelfinavir-derived from diglycerides or amino acids: synthesis, stability and anti-HIV activity.Org Biomol Chem. 2004 Feb 7;2(3):345-57. doi: 10.1039/b313119j. Epub 2004 Jan 5. Org Biomol Chem. 2004. PMID: 14747863
-
A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance.Biochemistry. 2003 Jan 28;42(3):631-8. doi: 10.1021/bi027019u. Biochemistry. 2003. PMID: 12534275
-
Discovery of HIV-1 protease inhibitors with picomolar affinities incorporating N-aryl-oxazolidinone-5-carboxamides as novel P2 ligands.J Med Chem. 2006 Dec 14;49(25):7342-56. doi: 10.1021/jm060666p. J Med Chem. 2006. PMID: 17149864
-
Development of HIV protease inhibitors: a survey.Prog Drug Res. 1998;51:1-31. Prog Drug Res. 1998. PMID: 9949858 Review.
-
HIV protease as a target for retrovirus vector-mediated gene therapy.Biochim Biophys Acta. 2000 Mar 7;1477(1-2):168-88. doi: 10.1016/s0167-4838(99)00272-1. Biochim Biophys Acta. 2000. PMID: 10708857 Review.
Cited by
-
Heterocycles in peptidomimetics and pseudopeptides: design and synthesis.Pharmaceuticals (Basel). 2012 Mar 8;5(3):297-316. doi: 10.3390/ph5030297. Pharmaceuticals (Basel). 2012. PMID: 24281380 Free PMC article.
-
Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors.Future Med Chem. 2011 Jul;3(9):1181-97. doi: 10.4155/fmc.11.68. Future Med Chem. 2011. PMID: 21806380 Free PMC article. Review.
-
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS.J Med Chem. 2016 Jun 9;59(11):5172-208. doi: 10.1021/acs.jmedchem.5b01697. Epub 2016 Jan 22. J Med Chem. 2016. PMID: 26799988 Free PMC article. Review.
-
The Pseudo-Symmetric N-benzyl Hydroxyethylamine Core in a New Series of Heteroarylcarboxyamide HIV-1 Pr Inhibitors: Synthesis, Molecular Modeling and Biological Evaluation.Biomolecules. 2021 Oct 26;11(11):1584. doi: 10.3390/biom11111584. Biomolecules. 2021. PMID: 34827582 Free PMC article.
-
An insight to the molecular interactions of the FDA approved HIV PR drugs against L38L↑N↑L PR mutant.J Comput Aided Mol Des. 2018 Mar;32(3):459-471. doi: 10.1007/s10822-018-0099-9. Epub 2018 Feb 3. J Comput Aided Mol Des. 2018. PMID: 29397520
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Chemical Information
